fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and
.: "evidence for decreased calcitonin gene-related peptide (cgrp) receptors and compromised responsiveness to cgrp of fetoplacental vessels in preeclamptic pregnancies."
. a senior northern ireland civil servant has apologised after hundreds of neurology patients were recalled for further testing.
.
'indian ip and liabilities law barrier to pharma r&d investment'
.